Learn how companies moved from tracking one sample type to many and how they conquered hurdles and expanded their knowledge base.
Chair: Olivier Casamitjana (Evotec EU)
Kristen Nailor (Genentech)
Building a State-of-the-Art Centralized Protein Inventory
Kristina McNab (Merck)
Merck Discovery Sample Management’s Further Venture into Biosample Management
Kelsey Ford (Eikon Therapeutics)
Cell Line Management on an Automated Scale: Biobanking and Inventory Control